Aspirin Market Report 2025 (Global Edition)

Global Aspirin Market Report 2025 Market Size Split by Distribution Channel Outlook: (Hospital and Retail Pharmacies, Online Channels)

Aspirin Market Report Description

We have various report editions of Aspirin Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.

The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.

Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.

Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.

Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.

Competitive Landscape of the Aspirin Market

The aspirin market is highly competitive, with key players like Bayer AG and Pfizer dominating through established brands and global distribution networks. Generic manufacturers in Asia contribute to intense price competition. Companies are increasingly focusing on R&D for new formulations and applications to maintain market share. Strategic partnerships and acquisitions are also prevalent, enabling firms to expand their geographical presence and product portfolios. Regulatory compliance and marketing strategies significantly influence the competitive dynamics.

In March 2023, the FDA granted approval to PLx Pharma Inc. for the Supplemental New Drug Applications (SNDAs) of VAZALORE 325 mg and 81 mg. VAZALORE is a liquid-filled aspirin capsule designed for patients with vascular disease and diabetes. (Source: https://www.managedhealthcareexecutive.com/view/fda-approves-sndas-for-vazalore) In November 2023, Janssen shared data from two recent analyses at the American Heart Association's (AHA) 2023 Scientific Sessions, highlighting that XARELTO, combined with aspirin, can effectively treat critical cardiovascular and adverse limb events. (Source: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001194)

Top Companies Market Share in Aspirin Industry: (In no particular order of Rank)

• Bayer AG
• Reckitt Benckiser Group PLC
• Pfizer Inc.
• GlaxoSmithKline PLC
• Novacyl (Seqens Group)
• Jilin Pharmaceutical Co.
• Ltd.
• Zhejiang Kangle Pharmaceutical Co.
• Ltd.
• Hubei Biocause Pharmaceutical Co.
• Ltd.
• Shandong Xinhua Pharmaceutical Co.
• Ltd.
• Wuhan Acetylsalicylic Acid Co.
• Ltd.
• Takeda Pharmaceutical Company Limited
• Sanofi S.A.
• Cipla Limited
• Dr. Reddy's Laboratories
• Mylan N.V.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Aspirin Market

Which Region Dominates the Aspirin Market in 2024?

According to Cognitive Market Research, North America leads the aspirin market due to high prevalence of cardiovascular diseases, strong healthcare infrastructure, and widespread awareness of aspirin’s preventive benefits. Favorable reimbursement policies and established retail networks further bolster the market.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is the fastest-growing region, driven by rising healthcare awareness, increasing geriatric population, and expanding access to OTC drugs. Growing e-commerce penetration and healthcare spending in countries like China and India contribute significantly to market growth, along with government initiatives promoting preventive healthcare.

The current report Scope analyzes Aspirin Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Aspirin Market Analysis

According to Cognitive Market Research, the global aspirin market size was estimated at USD 2514.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 1005.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 1.4% from 2024 to 2031.

• According to Cognitive Market Research, The United States aspirin market is projected to witness growth at a CAGR of 1.2% during the forecast period, with a market size of USD 793.58 million in 2024. Increased health awareness, growing prevalence of cardiovascular diseases, and rising demand for OTC pain relief medications will drive aspirin sales.
• The Canada aspirin market is projected to witness growth at a CAGR of 2.2% during the forecast period, with a market size of USD 120.70 million in 2024. The rise in elderly populations and greater consumer focus on preventive healthcare are contributing factors to aspirin sales growth in Canada. The Mexico aspirin market is projected to witness growth at a CAGR of 1.9% during the forecast period, with a market size of USD 91.53 million in 2024.

Europe Aspirin Market Analysis

According to Cognitive Market Research, the global aspirin market size was estimated at USD 2514.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 754.35 million in 2024 and will grow at a compound annual growth rate (CAGR) of 1.7% from 2024 to 2031.

• The United Kingdom aspirin market is projected to witness growth at a CAGR of 2.5% during the forecast period, with a market size of USD 126.73 million in 2024. The UK’s expanding aging population and increased cases of chronic pain and inflammation are pushing demand for aspirin-based treatments.
• The France aspirin market is projected to witness growth at a CAGR of 0.9% during the forecast period, with a market size of USD 69.40 million in 2024. The Germany aspirin market is projected to witness growth at a CAGR of 1.9% during the forecast period, with a market size of USD 149.36 million in 2024. Germany’s strong healthcare infrastructure, combined with a high number of lifestyle-related diseases, is driving greater consumption of aspirin. The Italy aspirin market is projected to witness growth at a CAGR of 1.1% during the forecast period, with a market size of USD 64.87 million in 2024. The Russia aspirin market is projected to witness growth at a CAGR of 0.7% during the forecast period, with a market size of USD 116.92 million in 2024. The Spain aspirin market is projected to witness growth at a CAGR of 0.8% during the forecast period, with a market size of USD 61.86 million in 2024. The Luxembourg aspirin market is projected to witness growth at a CAGR of 1.8% during the forecast period, with a market size of USD 23.38 million in 2024. The Portugal aspirin market is projected to witness growth at a CAGR of 1.5% during the forecast period, with a market size of USD 15.84 million in 2024. The Greece aspirin market is projected to witness growth at a CAGR of 2.0% during the forecast period, with a market size of USD 9.05 million in 2024. The Rest of Europe aspirin market is projected to witness growth at a CAGR of 0.4% during the forecast period, with a market size of USD 116.92 million in 2024.

Asia Pacific Aspirin Market Analysis

According to Cognitive Market Research, the global aspirin market size was estimated at USD 2514.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 578.34 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.

• According to Cognitive Market Research, China aspirin market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 260.25 million in 2024. Rapid urbanization, increasing healthcare awareness, and rising incidences of heart-related diseases are contributing to the rising demand for aspirin.
• The Japan aspirin market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 79.81 million in 2024. The India aspirin market is projected to witness growth at a CAGR of 7.0% during the forecast period, with a market size of USD 69.40 million in 2024. With a growing middle class and increasing awareness of preventive healthcare, India’s aspirin market is expanding rapidly in urban centers. The South Korea aspirin market is projected to witness growth at a CAGR of 4.3% during the forecast period, with a market size of USD 57.83 million in 2024. The Australia aspirin market is projected to witness growth at a CAGR of 4.9% during the forecast period, with a market size of USD 30.07 million in 2024. The South East Asia aspirin market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 39.91 million in 2024. The Rest of Asia Pacific aspirin market is projected to witness growth at a CAGR of 5.0% during the forecast period, with a market size of USD 41.06 million in 2024.

South America Aspirin Market Analysis

According to Cognitive Market Research, the global aspirin market size was estimated at USD 2514.5 Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD 125.73 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.6% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil aspirin market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 53.81 million in 2024. Brazil’s healthcare expansion, coupled with higher demand for over-the-counter pain relief solutions, is pushing aspirin sales across the country.
• The Argentina aspirin market is projected to witness growth at a CAGR of 3.5% during the forecast period, with a market size of USD 21.12 million in 2024. The rise in preventive healthcare trends, growing awareness of heart disease, and rising population are fueling aspirin sales in Argentina. The Colombia aspirin market is projected to witness growth at a CAGR of 2.4% during the forecast period, with a market size of USD 11.19 million in 2024. The Peru aspirin market is projected to witness growth at a CAGR of 2.8% during the forecast period, with a market size of USD 10.31 million in 2024. The Chile aspirin market is projected to witness growth at a CAGR of 2.9% during the forecast period, with a market size of USD 9.05 million in 2024. The Rest of Latin America aspirin market is projected to witness growth at a CAGR of 1.7% during the forecast period, with a market size of USD 20.24 million in 2024.

Middle East Aspirin Market Analysis

According to Cognitive Market Research, the global aspirin market size was estimated at USD 2514.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 50.29 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.9% from 2024 to 2031..

• The GCC Countries aspirin market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 21.52 million in 2024. Rising healthcare investments, an aging population, and higher incidence rates of cardiovascular diseases are spurring aspirin demand across the GCC.
• The Egypt aspirin market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 5.28 million in 2024. The South Africa aspirin market is projected to witness growth at a CAGR of 3.9% during the forecast period, with a market size of USD 7.95 million in 2024. The growing prevalence of chronic conditions and increasing access to healthcare services are expected to boost aspirin sales in South Africa. The Turkey aspirin market is projected to witness growth at a CAGR of 2.4% during the forecast period, with a market size of USD 4.32 million in 2024. The Nigeria aspirin market is projected to witness growth at a CAGR of 2.0% during the forecast period, with a market size of USD 5.28 million in 2024. The Rest of MEA aspirin market is projected to witness growth at a CAGR of 1.9% during the forecast period, with a market size of USD 5.93 million in 2024.

Aspirin Market Analysis

Segment Analysis of Aspirin Market

This report categorizes competitors in the pharmaceutical and healthcare market based on their product offerings and business models. It includes key details such as definitions, benefits, applications, technological advancements, and regional advantages for each type of pharmaceutical product, including small molecule drugs, biologics, and biosimilars.

Market growth figures, such as market share percentages, revenue, and growth rates (e.g., CAGR), are provided for each segment over the specified period (2019-2023). The report covers various segments

of Aspirin analyzed in this report are as follows:

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Aspirin Industry. Request a Free Sample PDF!

Segment Analysis of Aspirin Market

This report analyzes revenue growth in the pharma and healthcare industry at global, regional, and national levels, highlighting trends and opportunities for each application. It explores how sectors like pharmaceuticals, therapy, and healthcare monitoring use innovations to address healthcare needs. Key factors include market size, revenue contributions, technological advancements (e.g., AI-driven diagnostics), and regulatory considerations. The report also covers the value chain, identifying key players and processes within the industry. For more information, please request a sample or contact our research team.

Some of the key of Aspirin are:

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Aspirin Distribution Channel Outlook: Segment Analysis

Aspirin Market Distribution Channel Segment Analysis

According to Cognitive Market Research, the hospital and retail pharmacies segment holds the largest share of the market due to their role as trusted distribution channels for both prescription and OTC aspirin. Their accessibility in urban and rural areas, combined with pharmacist consultations, ensures steady sales. Additionally, bulk procurement by hospitals for in-patient cardiovascular treatments and post-surgery pain management contributes significantly to this segment’s strong market presence.

In the aspirin market, the online channels has been expanding at a rapid pace due to the convenience of doorstep delivery and increasing internet penetration. Rising adoption of e-commerce platforms, especially during and post-pandemic, has made online channels a preferred choice for purchasing aspirin. Discounts, subscription models, and access to a wider variety of products further attract consumers, boosting sales growth in this segment.

• Hospital and Retail Pharmacies
• Online Channels

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion